Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-09

Clinical Trial Update: A Phase I Clinical Study to Evaluate the PK, PD, Efficacy, and Safety of GB18 Injection in Patients With Tumor Cachexia [Phase 1]

View source ↗

Summary

Phase I clinical study to evaluate pharmacokinetics, pharmacodynamics, efficacy, and safety of GB18 Injection in patients with tumor cachexia; status listed as …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GB18 Injection (GB18)

Snippet

Sponsor: Kexing Biopharm Co., Ltd. | Conditions: Cachexia; Cancer | Phase 1 | Status: NOT_YET_RECRUITING